The Future of Genomics & Personalized Medicine: Genomics & Blood Cancers

Joining Vital Options CEO, Selma SchimmelThe Future of Genomics & Personalized Medicine: Keith Stewart, MD, Mayo Clinic; Anne Quinn Young, MPH, Multiple Myeloma Research Foundation (MMF); Scott Riccio, Leukemia and Lymphoma Society (LLS); Meghan Gutierrez, Lymphoma Research Foundation (LRF).

In this segment they discuss the growing role of genomics in blood cancer therapies and the ongoing pursuit of targeted therapies and personalized medicine.

ASH 2013 Sponsors

Comments